Sessioni Comunicazioni Orali


Ketamine and Pharmacology of pshychiatric diseases

Saturday, October 28th / 9.00-11.00
60KETAMINE INDUCED STRUCTURAL PLASTICITY IN HUMAN IPSC-DERIVED DOPAMINERGIC NEURONS
Collo G., Cavalleri L., Millan MJ., Chiamulera C., Spano PF., Merlo pich E.
61POST-SYNAPTIC GLUTAMATE DYSFUNCTION INDUCED BY KETAMINE SELF-ADMINISTRATION
Caffino L., Piva A., Mottarlini F., Giannotti G., Di chio M., Venniro M., Yew DT., Chiamulera C., Fumagalli F.
62METAPLASTIC TREATMENTS WITH KETAMINE AND MK-801 AFFECT INSTRUMENTAL APPETITIVE MEMORY RECONSOLIDATION IN RATS
Gerace E., Piva A., Di chio M., Padovani L., Pellegrini-giampietro DE., Chiamulera C.
63THE MULTIPLE EFFECTS OF THE KETAMINE ANALOG METHOXETAMINE: PRECLINICAL EVIDENCE
Fattore L., Zanda MT., Mutti A., Fratta W., Chiamulera C.
64Ketamine modulation of PSD gene expression: implication for pathophysiology and treatment of behavioral disorders
65Dopamine D3 receptors control dysbindin-dependent executive functions alterations relevant to schizophrenia
Leggio GM., Torrisi SA., Manag˛ F., Chisari M., Mastrogiacomo R., Mereu M., De luca MA., Ciranna L., Salomone S., Drago F., Papaleo F.
66Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: role of 5-HT2A receptor agonism
Scarselli M., Aringhieri S., Kolachalam S., Carli M.
67EFFECTS OF THE PPAR-ALPHA AGONIST FENOFIBRATE IN AN IMMUNE-MEDIATED NEURODEVELOPMENTAL MODEL OF PSYCHOSIS
Pistis M., Sagheddu C., Aroni S., Muntoni AL., Frau R., Fanni S., Pardu A., Devoto P., Melis M., De felice M.